See more : Zhonghong Pulin Medical Products Co., Ltd. (300981.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Zepp Health Corporation (ZEPP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zepp Health Corporation, a leading company in the Consumer Electronics industry within the Technology sector.
- Kwong Luen Engineering Holdings Limited (1413.HK) Income Statement Analysis – Financial Results
- PT Bank BTPN Tbk (BTPN.JK) Income Statement Analysis – Financial Results
- Perseus Mining Limited (PMNXF) Income Statement Analysis – Financial Results
- Zovio Inc (ZVOI) Income Statement Analysis – Financial Results
- Sam Woo Construction Group Limited (3822.HK) Income Statement Analysis – Financial Results
Zepp Health Corporation (ZEPP)
About Zepp Health Corporation
Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 2.50B | 4.14B | 6.25B | 6.43B | 5.81B | 3.65B | 2.05B | 1.56B | 896.46M |
Cost of Revenue | 1.84B | 3.34B | 4.94B | 5.10B | 4.34B | 2.71B | 1.55B | 1.28B | 785.87M |
Gross Profit | 657.78M | 803.12M | 1.31B | 1.33B | 1.47B | 939.45M | 494.70M | 276.15M | 110.59M |
Gross Profit Ratio | 26.36% | 19.39% | 20.89% | 20.71% | 25.25% | 25.77% | 24.14% | 17.74% | 12.34% |
Research & Development | 361.81M | 517.12M | 515.08M | 538.01M | 430.82M | 263.22M | 153.83M | 132.30M | 61.55M |
General & Administrative | 188.51M | 235.93M | 258.35M | 261.81M | 248.46M | 213.97M | 114.88M | 102.64M | 69.98M |
Selling & Marketing | 314.56M | 460.30M | 438.27M | 358.66M | 181.98M | 96.54M | 44.03M | 27.82M | 19.17M |
SG&A | 503.07M | 696.24M | 696.62M | 620.46M | 430.44M | 310.51M | 158.91M | 130.47M | 89.15M |
Other Expenses | 0.00 | 43.82M | 40.93M | -23.55M | 10.59M | 1.18M | 4.56M | 14.73M | 1.11M |
Operating Expenses | 864.88M | 1.21B | 1.21B | 1.16B | 861.26M | 573.73M | 312.73M | 262.77M | 150.71M |
Cost & Expenses | 2.70B | 4.55B | 6.16B | 6.26B | 5.21B | 3.28B | 1.87B | 1.54B | 936.57M |
Interest Income | 3.09M | 12.33M | 16.69M | 46.12M | 33.48M | 11.60M | 3.00M | 754.00K | 255.00K |
Interest Expense | 6.73M | 57.00M | 44.88M | 22.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 7.68M | 58.62M | 51.88M | 27.13M | 17.22M | 6.22M | 3.72M | 2.40M | 285.00K |
EBITDA | -134.39M | -354.09M | 93.94M | 105.35M | 623.70M | 357.60M | 185.69M | 15.78M | -39.83M |
EBITDA Ratio | -5.39% | -8.55% | 2.42% | 1.64% | 10.40% | 9.81% | 8.77% | 1.01% | -4.44% |
Operating Income | -207.10M | -410.24M | 93.94M | 78.22M | 606.48M | 365.72M | 181.97M | 13.38M | -40.11M |
Operating Income Ratio | -8.30% | -9.90% | 1.50% | 1.22% | 10.43% | 10.03% | 8.88% | 0.86% | -4.47% |
Total Other Income/Expenses | 173.70M | 356.25M | -77.21M | -37.57M | -513.25M | -309.52M | -152.58M | 15.48M | 1.36M |
Income Before Tax | -33.40M | -372.53M | 106.67M | 265.61M | 652.37M | 386.61M | 191.90M | 28.86M | -38.75M |
Income Before Tax Ratio | -1.34% | -8.99% | 1.71% | 4.13% | 11.22% | 10.61% | 9.37% | 1.85% | -4.32% |
Income Tax Expense | -2.23M | -65.88M | 10.75M | 31.15M | 77.89M | 52.04M | 27.61M | 3.09M | -897.00K |
Net Income | -212.12M | -306.66M | 95.92M | 228.75M | 575.20M | 340.05M | 167.68M | 23.95M | -37.85M |
Net Income Ratio | -8.50% | -7.40% | 1.53% | 3.56% | 9.90% | 9.33% | 8.18% | 1.54% | -4.22% |
EPS | -13.96 | -4.98 | 1.52 | 3.68 | 9.44 | 6.08 | 0.78 | -0.20 | -0.64 |
EPS Diluted | -13.96 | -4.98 | 1.45 | 3.51 | 8.99 | 6.04 | 0.78 | -0.20 | -0.64 |
Weighted Avg Shares Out | 15.20M | 61.57M | 63.04M | 62.12M | 60.91M | 55.94M | 59.43M | 59.43M | 59.43M |
Weighted Avg Shares Out (Dil) | 15.20M | 61.57M | 66.09M | 65.09M | 63.99M | 56.26M | 59.43M | 59.43M | 59.43M |
Zepp Health Corporation (ZEPP) Q3 2024 Earnings Call Transcript
Zepp Health Corporation Reports Third Quarter 2024 Unaudited Financial Results
Luxury Smart Jewelry Market Size, Share and Trends Analysis Report 2024-2030, Featuring Profiles of Oura Health, RINGLY, Samsung, Motiv, Boat and Zepp Health
Zepp Health Corporation to Report Third Quarter 2024 Financial Results on November 18, 2024
Zepp Health Launches Enhanced Zepp App 9: Elevating Personalized Health and Wellness for Amazfit Users Worldwide
Zepp Regains Compliance with NYSE Minimum Price Continued Listing Criterion
Zepp Health Corporation Announces Plan to Implement ADS Ratio Change
Amazfit T-Rex 3 Launches at IFA Berlin: Redefining Adventure for Modern Explorers
Zepp Health Corporation Announces Board Changes
Amazfit Named Official Wearable Partner & Timekeeper of HYROX
Source: https://incomestatements.info
Category: Stock Reports
What are the key factors affecting Zepp Health’s financial performance?
A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the cooperation with Xiaomi, the recognition of the Company’s self-branded products; the Company’s growth strategies; trends and competition in global …